‘Practice changing’: Ruxolitinib as second-line in chronic GVHDDecember 8, 2020TransplantPatient & Survivor Care
COVID-19 and risk of clotting: ‘Be proactive about prevention’December 8, 2020ThrombosisCOVID-19 Updates
Biden chooses California Attorney General Xavier Becerra to head HHSDecember 7, 2020Business of MedicineMixed Topics
Duvelisib response rate encouraging in phase 2 PRIMO trial of patients with r/r PTCLDecember 7, 2020T Cell Lymphomas
Cost is the main hurdle to broad use of caplacizumab for TTPDecember 7, 2020ThrombosisBleeding Disorders
No benefit from tranexamic acid prophylaxis in blood cancersDecember 7, 2020ThrombosisPatient & Survivor CareBleeding Disorders
